日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation.

一种靶向人类免疫缺陷病毒1型病毒颗粒成熟的新型小分子抑制剂

Blair Wade S, Cao Joan, Fok-Seang Juin, Griffin Paul, Isaacson Jason, Jackson R Lynn, Murray Edward, Patick Amy K, Peng Qinghai, Perros Manos, Pickford Chris, Wu Hua, Butler Scott L

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers

在健康志愿者中开展的 2% ruprintrivir 鼻喷雾剂混悬液预防和治疗实验诱发的鼻病毒感冒的 II 期随机、双盲、安慰剂对照研究

Hayden, Frederick G; Turner, Ronald B; Gwaltney, Jack M; Chi-Burris, Kathy; Gersten, Merril; Hsyu, Poe; Patick, Amy K; Smith, George J 3rd; Zalman, Leora S